Effect of beta-amyloid and tau pathology on functional network organization and memory in aging
Effect of beta-amyloid and tau pathology on functional network organization and memory in aging
批准号:
10368050
负责人:
Kaitlin Elizabeth Cassady
金额:
$6.76万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-04-01 至 2024-08-17
关键词:
AddressAgeAge-associated memory impairmentAgingAlzheimer disease detectionAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAmyloid beta-ProteinAnteriorAttentionBehavioralBrainCognitionDataDementiaEarly DiagnosisElderlyEpisodic memoryExhibitsFunctional Magnetic Resonance ImagingGoalsImpairmentIndividual DifferencesInferiorLeadLinkMeasuresMediatingMemoryMemory LossMemory impairmentModelingMolecularNeurobiologyNeurofibrillary TanglesNeuropsychologyPathogenesisPathologicPathologyPerformancePositron-Emission TomographyProcessReportingResearchRestRisk FactorsSemanticsSenile PlaquesSymptomsSystemTemporal LobeTestingTimeWorkabeta accumulationage relatedcognitive functiondementia riskepisodic memory impairmentexperimental studyhealthy aginginsightneural networkneuromechanismneuropathologynormal agingnovel strategiesobject recognitionpathological agingpublic health relevancerelating to nervous systemsegregationtau Proteinstau aggregationtherapy developmentyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The goal of the proposed research is to investigate a potential mechanism by which the accumulation of beta
amyloid (Aβ) plaques and tau tangles could lead to episodic memory impairments. A loss of episodic memory is
one of the hallmarks of age-related cognitive decline and is a major risk factor for dementia. Before the symptoms
of dementia occur in Alzheimer’s disease (AD), Aβ plaques and neurofibrillary tau tangles begin to appear in the
brain. This process typically starts in the neural systems associated with episodic memory and tracks closely
with age-related memory impairments. An important open question is how Aβ and tau accumulation lead to
memory decline. One possibility is that Aβ and tau may lead to memory loss through the disruption, or
‘dedifferentiation’, of episodic memory networks. For example, large-scale canonical networks, such as the
default mode, salience, and attention networks, have been reported to be less segregated in older vs. younger
adults, and such dedifferentiation has been associated with impaired performance on a variety of tasks.
However, the molecular and pathological substrate of these observations is unknown. I propose to test whether
the accumulation of Aβ and tau is associated with network segregation in the episodic memory system and
whether network segregation mediates the association between neuropathology and memory decline. In
preliminary analyses, I used resting state fMRI to measure functional network segregation in the neural systems
most associated with episodic memory (the anterior temporal (AT) and posteromedial (PM) networks) in older
and younger adults. I found that the AT and PM networks were significantly less segregated in older relative to
younger adults. Building on these findings, I will study older adults with Aβ and tau PET at baseline, and memory
performance at three time points over a period of about 6 years. My proposed research will test the following
hypotheses: (1) Increased Aβ/tau will be associated with less segregated AT/PM networks, (2) less segregated
AT/PM networks will predict worse episodic memory performance at baseline as well as change in performance
over time, and (3) more Aβ/tau will predict worse memory performance (at baseline and change in performance
over time), and network segregation will mediate the relationship between Aβ/tau and performance. Together,
the proposed experiments will test a model in which age-related increases in Aβ and tau lead to neural
dedifferentiation of intrinsic functional memory networks, which in turn leads to memory deficits. By studying this
episodic memory system in healthy older adults, we can advance our understanding of healthy aging and its
similarities to and differences from pathological aging, which could serve as a crucial building block for the early
detection of AD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effect of beta-amyloid and tau pathology on functional network organization and memory in aging
-
批准号:10614920
-
项目类别:
-
资助金额:$7.18万
-
财政年份:2021
-
负责人:Kaitlin Elizabeth Cassady
-
依托单位:
Somatosensory Dedifferentiation in the Aging Brain
-
批准号:9468899
-
项目类别:
-
资助金额:$3.54万
-
财政年份:2017
-
负责人:Kaitlin Elizabeth Cassady
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: